During January 2012–June 2018, 93.8% of active duty service members with human immunodeficiency virus infection who remained in care received continuous antiretroviral therapy (ART). Viral suppression was achieved in 99.0% within 1 year of ART initiation and in 96.8% at the last test during the surveillance period.